DNA nanospheres with microfluidics: a promising platform for cancer diagnosis?-Reference-Cited by-同舟云学术

DNA nanospheres with microfluidics: a promising platform for cancer diagnosis?

Published:2013-11 Issue:11 Volume:8 Page:1731-1733
ISSN:1743-5889
Container-title:Nanomedicine
language:en
Short-container-title:Nanomedicine

Author:

Fan Z Hugh¹,Tan Weihong²

Affiliation:

1. Interdisciplinary Microsystems Group, Department of Mechanical & Aerospace Engineering, J Crayton Pruitt Family Department of Biomedical Engineering, & Department of Chemistry, University of Florida, PO Box 116250, Gainesville, FL 32611, USA.

2. Center for Research at the Bio/Nano Interface, Department of Chemistry, Department of Physiology & Functional Genomics & Shands Cancer Center, University of Florida, Gainesville, FL 32611-7200, USA.

Publisher

Future Medicine Ltd

Subject

Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.futuremedicine.com/doi/pdf/10.2217/nnm.13.163

Reference20 articles.

1. American Cancer Society.Cancer Facts and Figures 2012. American Cancer Society, GA, USA (2012).

2. A Perspective on Cancer Cell Metastasis

3. National Cancer Institute.The Early Detection Research Network Fourth Report.NIH, MD, USA (2008).

4. Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

5. HenryJB.Clinical Diagnosis and Management by Laboratory Methods (19th Edition). Saunders, PA, USA (1996).

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetic nanoparticles in microfluidics-based diagnostics: an appraisal;Nanomedicine;2021-06

2. Microfluidic devices and drug delivery systems;Biomedical Applications of Microfluidic Devices;2021

3. 3D models in the new era of immune oncology: focus on T cells, CAF and ECM;Journal of Experimental & Clinical Cancer Research;2019-03-22

4. Programmable and Multifunctional DNA‐Based Materials for Biomedical Applications;Advanced Materials;2018-02

5. Reduction in Migratory Phenotype in a Metastasized Breast Cancer Cell Line via Downregulation of S100A4 and GRM3;Scientific Reports;2017-06-14